20 September 2025, Volume 39 Issue 9
    

  • Select all
    |
    Supervision & Administration: Column: New Regulations on Microbiology in the Chinese Pharmacopoeia 2025 Edition
  • Yu Meng, Wang Sijin, Ma Shihong
    Chinese Pharmaceutical Affairs. 2025, 39(9): 969-973. https://doi.org/10.16153/j.1002-7777.2025-07-0035
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To develop a standardized Burkholderia cepacia complex (referred to as “Bcc”) testing method for the Chinese Pharmacopoeia (referred to as the “Chinese Pharmacopoeia”) 2025 Edition, thereby enhancing the national standards for China's pharmaceutical microbial contamination control and improving regulatory oversight. Methods: A systematic methodological evaluation of Bcc detection protocols was conducted by referring to the international standards for pharmaceuticals, cosmetics, and related products. By collaborating with 11 drug control laboratories under a national pharmaceutical standards enhancement initiative, critical parameters were optimized, including enrichment conditions, selective media, and confirmatory assays. Methodvalidation was performed using both spiked and real-world samples, followed by iterative revisions based on interlaboratory verification. Results: The reference strains for quality control, an optimized enrichment and isolation system, and selective culture media with improved specificity were specified in the finalized Chinese Pharmacopoeia 2025 Edition Bcc test method. Additionally, a definitive species-level taxonomic list of Bcc members was incorporated to facilitate accurate strain identification. Conclusion: On the basis of aligning with global regulatory standards, the establishment and inclusion of the Bcc test method addresses critical gaps in China's pharmaceutical microbiological quality control. Its adoption in the Chinese Pharmacopoeia 2025 Edition represents a pivotal advancement in the compendium's microbial standards, ensuring enhanced detection of opportunistic pathogens in pharmaceutical products.
  • Wang Ganggang, Wang Sijin, Ma Shihong
    Chinese Pharmaceutical Affairs. 2025, 39(9): 974-979. https://doi.org/10.16153/j.1002-7777.2025-07-0033
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To strengthen the implementation of the main responsibility for microbial control of pharmaceutical water, and to enhance the guidance on the full life cycle microbial monitoring and control of pharmaceutical water in the industry, the “Guideline for Microbiological Monitoring and Control of Pharmaceutical Water” was established. Methods: Four institutes for drug inspection and many pharmaceutical manufactures were organized to sort out the key points of the guideline through the investigation of testing methods, exploration of the application of rapid microbial methods, comparison of regulations and standards, questionnaire surveys, and on-site investigations of enterprises. Results: A full-chain technical framework covering the microbial characteristics, monitoring methods, process control, and risk prevention and control of pharmaceutical water was constructed Chinese Pharmacopoeia 2025 Edition has newly added the “Guideline 9209 for Microbiological Monitoring and Control of Pharmaceutical Water”. Conclusion: This guideline is an important supplement to the revision and implementation of product standards and general rules for pharmaceutical water, and also represents a significant measure for aligning Chinese Pharmaceutical water standard system with international advanced technical concepts.
  • Xiao Huang, Zhou Fayou, Wang Jing, Dai Hui, Ma Shihong
    Chinese Pharmaceutical Affairs. 2025, 39(9): 980-984. https://doi.org/10.16153/j.1002-7777.2025-07-0030
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To address the deficiencies in the selection, validation, and application of disinfectants by pharmaceutical manufacturers, and in line with the core concept of “whole-process control” in the Chinese Pharmacopoeia (referred to as the “Chinese Pharmacopoeia”) 2025 Edition, to establish a scientific and operational guideline for the evaluation of disinfectant efficacy. Methods: By integrating domestic and international pharmacopoeia standards (USP, JP) and national standards (GB/T series), technical specifications were systematically formulated, covering the classification of disinfectants, methods for efficacy evaluation, and criteria for result determination. Results: The application scope of chemical disinfectants in the pharmaceutical environment was clarified, and two test methods, the suspension method and the carrier method were listed, and the threshold for determining disinfection efficacy was set based on international standards (a reduction of ≥3 in the lg value for bacterial or fungal vegetative cells, and a reduction of ≥2 in the lg value for spores or spores). Conclusion: The establishment of this guideline has promoted the improvement of the microbial contamination control standard system and provided technical support for the microbial safety management in the pharmaceutical production process.
  • Xi Hao, Sun Yang, Wang Chong, Xu Miao
    Chinese Pharmaceutical Affairs. 2025, 39(9): 985-1006. https://doi.org/10.16153/j.1002-7777.2025-06-0004
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To provide references for further optimizing the National Drug Quality Sampling and Testing process management strategies by comparing the checklist requirements and recommended procedural framework of the Market Surveillance and Control (MC) module in the GBT assessment tool. Methods: The literature research method was adopted to summarize the checklist requirements and recommended procedural framework of the MC module in the GBT assessment tool, and key risk factors according to the proposed targeted process management optimization strategies of the National Drug Quality Sampling and Testing program were analyzed. Results: Comprehensive analysis revealed that 17 indicators were highly relevant to the National Drug Quality Sampling and Testing program, covering six aspects including legal and regulatory framework construction, organizational management structure, human resource management, procedural document management, system and data management, and risk communication and information disclosure. The analysis of the MC module shows that a good post-market quality surveillance framework should have a regulatory framework and work procedures covering the entire process from sampling, testing research, to risk assessment and mitigation; establish a clear and stable, well-defined organizational structure and be able to form regulatory decisions comprehensively and objectively; construct a personnel management and training system conducive to the implementation of post-market quality surveillance activities; build a database management platform covering the entire process of surveillance, providing trend analysis and regulatory tools to guide the prevention and control of counterfeit and substandard medical products, as well as assessment indicators tailored to different functional requirements, and simultaneously form an international risk information sharing and collaborative disposal system. Conclusion: As a specific form of post-market quality surveillance activities, the National Drug Quality Sampling and Testing program, by further refining the process management system in accordance with the above framework requirements, is conducive to forming management standards and risk management pathways with international compatible. This, in turn, enables a more profound participation in global safety governance. It is suggested to strengthen online sampling and expand international cooperation at the regulatory framework level; establish a sound decision-making consultation system in terms of organizational management structure; construct a training effect evaluation mechanism in terms of human resource management; build and enrich trend analysis tools in terms of system and data management; and enhance the communication, and reinforce an international risk information sharing and collaborative disposal system in terms of risk communication and information disclosure.
  • Zhang Dan, Liu Shan, Leng Yang, Meng Kejie, Xiong Xiaoli, Xie Yaoyao
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1007-1016. https://doi.org/10.16153/j.1002-7777.2025-04-0022
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: By statistically analyzing the deficiencies found in routine inspections of non-compliant drug wholesale enterprises and retail chain headquarters in Guizhou Province within three years after the implementation of the “Drug Inspection Management Measures (Trial)”, this study aims to identify common issues and risk points, propose corresponding measures and suggestions, and provide references for drug supply enterprises to standardize operations and for regulatory authorities to better control risks in the drug circulation process and develop more targeted supervision strategies. Methods: A retrospective statistical analysis was conducted on the deficiencies identified in 43 non-compliant enterprises during routine inspections in Guizhou Province from 2022 to 2024. The key problematic areas were identified and analyzed. Results: A total of 440 deficiencies were recorded, including 40 critical deficiencies, 235 major deficiencies, and 165 minor deficiencies. High-frequency deficiencies were primarily concentrated in areas: quality management system documentation, storage and maintenance, organizational and quality management responsibilities, personnel and training, and facilities and equipment, accounting for 60% of the total deficiencies. Conclusion: Enterprises should continuously enhance legal and safety awareness, strengthen primary responsibility in operations, improve quality management systems, reinforce personnel training and facility management, and meet hardware requirements. Regulatory authorities should intensify the dissemination of laws and regulations, promote collaborative social supervision, expand professional teams through resource coordination, form regulatory synergy, and innovate supervision methods to improve precision and effectiveness.
  • Regulatory Technology
  • Du Ying, Sui Silian, Tan Dejiang, Zhang Heng, Chen Chen, He Qing, Chen Hua, Xiang Xinhua
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1017-1026. https://doi.org/10.16153/j.1002-7777.2025-05-0032
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To explore a more accurate and profound approach to distinguish the testing capabilities of laboratories by using three evaluation methods to evaluate the results of proficiency testing for the kinetic turbidimetric method of bacterial endotoxins. Methods: First, the results were collected from a round of proficiency testing program designed with repeated strategy of the kinetic turbidimetric method of bacterial endotoxins. Then, the assigned value and the proficiency testing standard deviation were calculated by using the robust algorithm A and robust algorithm S respectively under the logarithmic scale, and subsequently, three evaluation methods were utilized to assess the testing capabilities of the laboratories which were the quality acceptance criterion (ranging from 50% to 200%), the Z-scores, and the plots of ranges against averages. Results: After statistical processing of the test data under the logarithmic (log10) scale from forty laboratories, the assigned value X was 4.074 which obtained by using the robust algorithm A, and the proficiency testing standard deviation (σPT) was 0.042 by using the robust algorithm S. The lab capability,(1) When accessed by using the quality acceptance criterion method, the test results of all forty laboratories fell within the range of 50%-200% of the assigned value X, and thus were all categorized as satisfactory;(2) When accessed by using the Z-scores method: a. Thirty-six laboratories were rated as satisfactory, four as questionable, and none as unsatisfactory when using the mean of the intra-laboratory logarithmic results to calculate the Z-scores. b. Thirty-one laboratories were rated as satisfactory, six as questionable, and three as unsatisfactory when using each logarithmic result of the intra-laboratory to calculate the Z-scores; (3) When accessed by using the plots of ranges against averages method, twenty-five laboratories were rated as satisfactory, eight as questionable, and seven as unsatisfactory. Conclusion: Although the international community generally adopts the quality acceptance criterion method to make a final evaluation of whether the participating laboratories' capabilities (bacterial endotoxin proficiency testing) are satisfactory or not, it could be better distinguished the capability of the participating laboratories and could be more intuitively showed the bias from the assigned value and the degree of dispersion of each participating laboratory by the plots of ranges against averages method among these three evaluation methods.
  • Xiao Yangyang, Lin Jinfeng, Zhang Jinju, Huang Guokai, Lu Jia, Liu Xiaoxiao
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1027-1037. https://doi.org/10.16153/j.1002-7777.2025-05-0040
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To develop a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method for the effective identification of Sophora tonkinensis and adulterant Sophora flavescens. Methods: By comparing and analyzing the DNA barcodes of Sophora tonkinensis and adulterant Sophora flavescens, a key differential site of Sophora tonkinensis was found and the corresponding PCR-RFLP method was established. Besides, the reaction system and procedure of PCR-RFLP were optimized, including the methodological investigation of annealing temperature, reaction cycle, instrument brand, the amount of sample DNA template and enzyme digestion reaction system. Results: The ITS2 sequences between Sophora tonkinensis and adulterant Sophora flavescens were significantly different. Compared with Sophora flavescens, there was a key differential site in Sophora tonkinensis that could be recognized and cut into two parts in 200-300 bp by the restriction enzyme BamHI after PCR-RFLP. However, adulterant Sophora flavescens had no band in 200-300 bp. Besides, the optimum annealing temperature was 58 ℃ and the optimum reaction cycle was 35. Conclusion: An effective PCR-RFLP method was established to distinguish Sophora tonkinensis and adulterant Sophora flavescens.
  • Zhang Pei, Wang Yumeng, Yin Lei, Li Jun
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1038-1047. https://doi.org/10.16153/j.1002-7777.2025-05-0042
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To provide data references for fresh cutting and clinical research of Bo Atractylodes macrocephala Koidz.(BAMK) by analyzing and comparing fresh cutting and traditional cutting of BAMK from the same batch. Methods: The differences between decoction pieces prepared by fresh cutting and traditional cutting of BAMK were explored by the properties, identification (thin layer chromatography), and the determination of moisture, total ash, extract, volatile oil, as well as HPLC fingerprints combined with chemometrics. Results: There were no obvious differences in properties, identification, extract and volatile oil between different cutting methods. The chromatographic fingerprints of 20 BAMK decoction pieces were marked and 15 common peaks were confirmed, and six chemical components were pointed out. The similarities of the fingerprints were 0.958-0.998. PCA was used to sort the 20 batches of BAMK decoction pieces, and the results showed that the quality of decoction pieces by fresh cutting was generally greater than that by traditional cutting, while the quality stability and uniformity of decoction pieces by traditional cutting were better. OPLS-DA found 7 differential components, all of which had higher contents in fresh cutting pieces than in traditional cutting pieces, and t-test revealed that neochlorogenic acid, atracylenolide Ⅰ and atracylenolide Ⅱ were the distinguishing points between different cutting methods. Conclusion: The fresh cutting technology of BAMK has feasibility. This study can provide references for the subsequent quality standard research.
  • Research Progress
  • Wang Yuan, Li Jie
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1048-1054. https://doi.org/10.16153/j.1002-7777.20240232
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: Adjuvants for traditional Chinese herbs processing are an important part of traditional Chinese herbs, and elucidating the mechanism of processing adjuvants is a powerful starting point for promoting the modernization of traditional Chinese herbs. This article summarizes the research progress on the mechanism of adjuvants for traditional Chinese herbs processing, and provides a reference for optimizing the processing technology of traditional Chinese medicine, establishing standards for processing excipients, and supervising drug quality. Methods: The relevant literatures of traditional Chinese medicine processing adjuvants in recent years were summarized, the research methods and results adopted by them were compared and analyzed, and the existing problems and countermeasures in the current research were discussed. Results and Conclusion: Studies showed that adjuvants used in processing of traditional Chinese herbs can play roles in solubilizing, attenuating, synergizing, absorption-promoting and other aspects, consequently, affecting the effectiveness and safety of the drug. We should take full advantage of modern analytical techniques to compare the changes of chemical composition of adjuvants before and after processing, and carry out systematic research by combining pharmacodynamic and pharmacokinetic methods.
  • Xu Beijie, Zhao Yuechen, Liu Jie, Dai Shengyun, Zhao Xu, Zheng Jian
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1055-1073. https://doi.org/10.16153/j.1002-7777.2025-06-0022
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To summarize and analyze the recent research on the Uyghur medicine Nymphaeae Flos, and provide references for establishing its quality control system and resource conservation. Methods: Relevant domestic and international literature were reviewed and analyzed to summarize the chemical compositions, pharmacological effects, quality control, and resources status of Nymphaeae Flos. Results and Conclusion: The main bioactive chemical constituents of Nymphaeae Flos are flavonoids and polyphenols, followed by coumarins, terpenoids, amino acids, alkaloids, fatty acids, and other compounds. Modern pharmacological studies have demonstrated that it possesses significant medicinal value, including hypoglycemic, hypolipidemic, anti-inflammatory, antibacterial, antioxidant, neureprotective, hepatoprotective, preventive of acute lung injury, and renal protection effects. However, the current quality control system of Nymphaeae Flos has limitations and the existing standard indicators are single and cannot fully reflect the quality of the medicinal materials, and thus require further improvement. Concurrently, due to habitat destruction, the wild Nymphaeae Flos resources are increasingly depleted, and species conservation is urgent.
  • Hospital Pharmacy
  • Qu Tiantian, Wang Cong, Wang Haiyan, Cao Yuhe
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1074-1082. https://doi.org/10.16153/j.1002-7777.2025-04-0003
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To construct a system of capability indexes and evaluate credibility and effectiveness of drug administrators in the drug management of clinical trial institutions. Methods: The Delphi method (expert correspondence inquiry) and analytic hierarchy process were employed. Relevant domestic and foreign literature was referred to. Through expert consultation and discussion within research group, a competence index system for clinical trial drug administrators was established. The AHP was applied to determine the weights of indicators at all levels. The reliability of the results was evaluated through a questionnaire survey. Results: A total of 21 experts were selected for the consultation, including 16 female experts (76.19%). The age of the experts was 38.32±6.85 years; 19 experts (90.48%) had a master's degree or above, and 9 experts (42.86%) had a deputy associate senior professional titles or above (42.86%). The average duration of their engagement in drug clinical trial work was 6.98±2.01 years. The recovery rates of the questionnaires in both rounds of expert consultation were 100%, indicating high expert engagement. The familiarity degree of the experts with the consultation content was 0.942, the basis degree of the experts' judgment was 0.933, and the authority degree of the experts was 0.937, indicating that the consultation results were relatively reliable. The coordination degree of expert' opinions was expressed by the intraclass correlation coefficient, and both the primary and the secondary indicators were higher than or equal to 0.75, indicating high reliability. A significance level of P<0.05 confirmed statistical consistency. After two rounds of consultations, the core competency evaluation scale for pharmacy dispensers was finally determined, including six primary indicators and sixty-six secondary indicators. Weight analysis revealed that among the six primary indicators, the weight value of “possession of drug clinical trial expertise” was the highest, and the weight scores of all secondary indicators under the primary indicators were also relatively high. Questionnaire survey results confirmed good internal consistency of the indicator system. Conclusion: The evaluation index system model of the ability of hospital pharmaceutical administrator constructed in this study can provide reference basis for the improvement of the ability of hospital pharmaceutical and the training selection of drug clinical trial pharmaceutical administrator.
  • Ge Sijie, Zhang Siyu, Liu Yuting, Qi Jianhang
    Chinese Pharmaceutical Affairs. 2025, 39(9): 1083-1088. https://doi.org/10.16153/j.1002-7777.2025-06-0053
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Objective: To establish an intelligent logistics model based on rail cars in the central pharmacy and evaluate its application effectiveness. Methods: A medication delivery system utilizing the rail car logistics system was developed and refined. The traditional manual logistics model and the intelligent logistics model were compared and evaluated using metrics including drug delivery time, drug delivery error count, labor costs, and departmental satisfaction scores. Results: The central pharmacy implemented an intelligent logistics model featuring human-robot collaboration, barcode-scanning delivery, real-time alerts, and closed-loop traceability. Drug delivery time and error count decreased by 65.92% and 63.01%, respectively. Labor costs were reduced, with logistics personnel decreasing from 11 to 5. Clinical department satisfaction scores reached above 93 points. Conclusion: The intelligent logistics model based on rail car enhances drug delivery efficiency, reduces errors, and improves pharmacy service levels.